In particular BioNTech from the article was founded 2008. This is their first publicly available "product" - it applies their vision for cancer treatment to specific SARS-nCoV-2 proteins (arguably I don't know if they're working on other ideas as well).

They might be working on this particular vaccine since 2020, but AFAIK they have been working on the specific principle the vaccine uses since 2008.